Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL

Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice

(2011) Niels Nijstad et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I

(2010) Estelle Nobécourt et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Anti-oxidant properties of high-density lipoprotein and atherosclerosis

(2010) Eugene A Podrez   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Inflammation reduces HDL protection against primary cardiac risk

(2010) James P. Corsetti et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol

(2009) Robin P.F. Dullaart et al.   ATHEROSCLEROSIS

Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans

(2009) Laura Calabresi et al.   CIRCULATION

HDL as a Biomarker, Potential Therapeutic Target, and Therapy: FIG. 1.

(2009) Mohamad Navab et al.   DIABETES

Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study

(2009) Omer T. Njajou et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

A catalogue of reporting guidelines for health research

(2009) I. Simera et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study

(2009) A. G. Holleboom et al.   JOURNAL OF LIPID RESEARCH

The effect of obesity on health outcomes

(2009) John B. Dixon   MOLECULAR AND CELLULAR ENDOCRINOLOGY

High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus

(2008) Robin P. F. Dullaart et al.   CLINICAL ENDOCRINOLOGY

Why is HDL functionally deficient in type 2 diabetes?

(2008) Anatol Kontush et al.   Current Diabetes Reports

HDL: bridging past and present with a look at the future

(2008) Angelo M. Scanu et al.   FASEB JOURNAL

Plasma Lecithin: Cholesterol Acyltransferase Activity Is Elevated in Metabolic Syndrome and Is an Independent Marker of Increased Carotid Artery Intima Media Thickness

(2008) Robin P. F. Dullaart et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Beyond High-Density Lipoprotein Cholesterol Levels

(2008) Emil M. deGoma et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

(2008) Theodore Mazzone et al.   LANCET